Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam

Adam B. Shapiro(NKT Therapeutics (United States)), Alita A. Miller(NKT Therapeutics (United States))

Frontiers in Microbiology

July 19, 2021

10.3389/fmicb.2021.709974

Cited by 75

Related Papers

No related papers found

Powered by citation graph analysis